Known information
- Welcomes the opportunity to collaborate with innovators who share a determination to develop transformative gene therapies for patients
- Plays a key role in strategic collaborations with industry leaders like AbbVie, CRISPR Therapeutics, and Prevail Therapeutics
About Capsida
Capsida develops targeted, non-invasive intravenous gene therapies for rare and common diseases, with a focus on CNS and ophthalmology disorders.